Apomorphine-evoked redistribution of neurokinin-3 receptors in dopaminergic dendrites and neuronal nuclei of the rat ventral tegmental area.
Mammalian neurokinin-3 (NK(3)) receptors of the tachykinin family of neuropeptides have been shown to activate dopaminergic neurons of the ventral tegmental area (VTA), a midbrain area displaying dopaminergic dysfunctional activity in schizophrenia. The recent finding of NK(3) receptors in VTA neuronal nucleus highlights a new level of neuromodulation, in addition to the traditional tachykinin-induced NK(3) receptor internalization and activation of second messenger signaling pathways. The function of nuclear NK(3) receptors is still unknown. It is also unclear how dopaminergic activation is affecting the NK(3) receptor distribution in the VTA. In the present study, trafficking of the NK(3) receptor in somatodendritic profiles of dopaminergic and non-dopaminergic neurons of the rat VTA was investigated following acute systemic administration of the dopamine D(1)/D(2) receptor agonist apomorphine. VTA sections were dual immunolabeled for the NK(3) receptor (immunogold) and the dopamine synthesizing enzyme tyrosine hydroxylase (TH, immunoperoxidase). Electron microscopic quantifications of somatic and dendritic densities of NK(3) immunogold particles with or without TH immunolabeling were compared in vehicle-injected or apomorphine-injected rats. In dopaminergic (TH) neurons, apomorphine evoked a significant increase in NK(3) receptor densities in cytoplasmic and nuclear portions of the soma. These changes were accompanied by a respective decrease and increase in plasmalemmal and cytoplamic NK(3) receptor densities in dopaminergic dendrites. In non-TH neurons, presumably GABAergic neurons of the VTA, the NK(3) receptor densities in somata and dendrites were not significantly altered by apomorphine. The results suggest that dopaminergic receptor activation is inducing a rapid mobilization of NK(3) receptors in VTA dopaminergic neurons. The apomorphine-evoked NK(3) receptors plasticity might reflect dendritic internalization and translocation of NK(3) receptors toward the soma and nucleus. This trafficking is not observed in non-dopaminergic neurons of the VTA. The selective apomorphine-evoked redistribution of VTA NK(3) receptors might have important implications in normal or pathological conditions such as schizophrenia.
Maryland Psychiatric Research Center, University of Maryland School of Medicine, Maple and Locust streets, Baltimore, MD 21228, USA.
K
K
Misono
A
A
Lessard
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D003712:Dendrites / Q000187:drug effects* / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology*; D059290:Dopaminergic Neurons / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D051381:Rats; D017207:Rats, Sprague-Dawley; D018042:Receptors, Neurokinin-3 / Q000378:metabolism*; D017557:Ventral Tegmental Area / Q000187:drug effects* / Q000378:metabolism
D018491:Dopamine Agonists; D018042:Receptors, Neurokinin-3; D001058:Apomorphine